Does BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Cause Erythema? 127 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 127 reports of Erythema have been filed in association with BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS. This represents 72.2% of all adverse event reports for BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS.
127
Reports of Erythema with BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS
72.2%
of all BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS reports
0
Deaths
88
Hospitalizations
How Dangerous Is Erythema From BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS?
Of the 127 reports, 88 (69.3%) required hospitalization.
Is Erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS. However, 127 reports have been filed with the FAERS database.
What Other Side Effects Does BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Cause?
Nausea (139)
Anaemia (132)
Headache (132)
Pyrexia (132)
Constipation (128)
Pain (128)
Female genital tract fistula (127)
Oral candidiasis (126)
Proctitis (126)
Radiculopathy (126)
What Other Drugs Cause Erythema?
ADAPALENE (38,965)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (30,872)
DUPILUMAB (10,877)
ADALIMUMAB (4,829)
ETANERCEPT (3,733)
AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE (3,462)
INFLIXIMAB (2,919)
METHOTREXATE (2,835)
SECUKINUMAB (2,824)
RITUXIMAB (2,460)
Which BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Alternatives Have Lower Erythema Risk?
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BILASTINE
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMATOPROST
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMATOPROST\TIMOLOL
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMEKIZUMAB
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMEKIZUMAB-BKZX